PFE Pfizer Inc

Price (delayed)

$37.28

Market cap

$207.22B

P/E Ratio

23.9

Dividend/share

$1.52

EPS

$1.56

Enterprise value

$268.78B

Sector: Healthcare
Industry: Drug Manufacturers - General

Pfizer Inc. is an American multinational pharmaceutical corporation. It is one of the world's largest pharmaceutical companies and ranked 57 on the 2018 Fortune 500 list of the largest United ...

Highlights

The quick ratio has soared by 86% YoY but it has contracted by 5% from the previous quarter
The price to earnings (P/E) is 59% higher than the last 4 quarters average of 15.0 and 24% higher than the 5-year quarterly average of 19.3
Pfizer's EPS has decreased by 47% YoY and by 39% from the previous quarter

Key stats

What are the main financial stats of PFE
Market
Shares outstanding
5.56B
Market cap
$207.22B
Enterprise value
$268.78B
Valuations
Price to earnings (P/E)
23.9
Price to book (P/B)
3.17
Price to sales (P/S)
4.26
EV/EBIT
31.73
EV/EBITDA
19.78
EV/Sales
5.52
Earnings
Revenue
$48.65B
EBIT
$8.47B
EBITDA
$13.59B
Free cash flow
$10.32B
Per share
EPS
$1.56
Free cash flow per share
$1.86
Book value per share
$11.74
Revenue per share
$8.75
TBVPS
$15.86
Balance sheet
Total assets
$178.98B
Total liabilities
$113.49B
Debt
$63.15B
Equity
$65.26B
Working capital
$13.59B
Liquidity
Debt to equity
0.97
Current ratio
1.4
Quick ratio
0.93
Net debt/EBITDA
4.53
Margins
EBITDA margin
27.9%
Gross margin
79.9%
Net margin
17.9%
Operating margin
17.5%
Efficiency
Return on assets
5%
Return on equity
13.5%
Return on invested capital
8.3%
Return on capital employed
5.8%
Return on sales
17.4%
Dividend
Dividend yield
4.08%
DPS
$1.52
Payout ratio
97.4%

PFE stock price

How has the Pfizer stock price performed over time
Intraday
2%
1 week
1.58%
1 month
0.03%
1 year
-6.38%
YTD
1.28%
QTD
1.28%

Financial performance

How have Pfizer's revenue and profit performed over time
Revenue
$48.65B
Gross profit
$38.85B
Operating income
$8.5B
Net income
$8.69B
Gross margin
79.9%
Net margin
17.9%
Pfizer's net income has decreased by 46% YoY and by 39% QoQ
PFE's net margin is down by 42% YoY and by 38% from the previous quarter
The operating income has contracted by 16% YoY and by 5% from the previous quarter
The company's operating margin fell by 8% YoY and by 3.8% QoQ

Growth

What is Pfizer's growth rate over time

Valuation

What is Pfizer stock price valuation
P/E
23.9
P/B
3.17
P/S
4.26
EV/EBIT
31.73
EV/EBITDA
19.78
EV/Sales
5.52
The price to earnings (P/E) is 59% higher than the last 4 quarters average of 15.0 and 24% higher than the 5-year quarterly average of 19.3
Pfizer's EPS has decreased by 47% YoY and by 39% from the previous quarter
PFE's P/B is 6% above its last 4 quarters average of 3.0 but 3.9% below its 5-year quarterly average of 3.3
PFE's P/S is 12% above its last 4 quarters average of 3.8 and 3.9% above its 5-year quarterly average of 4.1
Pfizer's revenue has decreased by 8% YoY

Efficiency

How efficient is Pfizer business performance
The company's return on invested capital has shrunk by 62% YoY and by 54% QoQ
Pfizer's ROA has plunged by 50% YoY and by 40% from the previous quarter
Pfizer's ROS has decreased by 50% from the previous quarter and by 49% YoY
The ROE fell by 49% YoY and by 39% QoQ

Dividends

What is PFE's dividend history
DPS
$1.52
Dividend yield
4.08%
Payout ratio
97.4%
Recent dividends

Financial health

How did Pfizer financials performed over time
PFE's total assets is 58% greater than its total liabilities
The quick ratio has soared by 86% YoY but it has contracted by 5% from the previous quarter
PFE's debt is 3.2% less than its equity
The debt to equity has grown by 20% YoY but it has contracted by 2% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.